Advertisement
Advertisement

CERS

CERS logo

Cerus Corp

2.35
USD
Sponsored
+0.03
+1.29%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

2.39

+0.04
+1.66%

CERS Earnings Reports

Positive Surprise Ratio

CERS beat 27 of 43 last estimates.

63%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$62.83M
/
-$0.01
Implied change from Q1 26 (Revenue/ EPS)
+9.39%
/
--
Implied change from Q3 25 (Revenue/ EPS)
+19.23%
/
--

Cerus Corp earnings per share and revenue

On Jul 30, 2026, CERS reported earnings of -0.01 USD per share (EPS) for Q1 26, beating the estimate of -0.01 USD, resulting in a 26.47% surprise. Revenue reached 57.44 million, compared to an expected 62.15 million, with a -7.58% difference. The market reacted with a +33.99% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 62.83 million USD, implying an increase of 0.00% EPS, and increase of 9.39% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
logo
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
logo
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
logo
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
logo
Apyx Medical Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+16.27%
logo
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
logo
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
logo
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
logo
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
logo
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-
Actual
$0.16
Surprise
-
FAQ
For Q1 2026, Cerus Corp reported EPS of -$0.01, beating estimates by 26.47%, and revenue of $57.44M, -7.58% below expectations.
The stock price moved up 33.99%, changed from $2.03 before the earnings release to $2.72 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 5 analysts, Cerus Corp is expected to report EPS of -$0.01 and revenue of $62.83M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement